Clearside Biomedical Inc buy Chardan Capital
Start price
14.10.24
/
50%
€1.04
Target price
14.10.25
€5.50
Performance (%)
-73.65%
End price
15.10.25
-
Summary
This prediction is currently being closed. Massive losses of -73.65% have been the result for the BUY prediction by Chardan_Capital. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Clearside Biomedical Inc | - | - | - |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% |
Comments by Chardan_Capital for this prediction
In the thread Clearside Biomedical Inc diskutieren
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
In the thread Trading Clearside Biomedical Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Chardan_Capital for Clearside Biomedical Inc
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€0.86
28.03.25
28.03.25
€5.56
28.03.26
28.03.26
-67.49%
30.03.26
30.03.26
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€0.88
21.08.24
21.08.24
€5.39
21.08.25
21.08.25
-61.59%
22.08.25
22.08.25

